Amélie Chollet | CMS – Global Relay Intelligence & Practice

Amélie Chollet | CMS

Amélie Chollet is a partner in CMS’s Life Sciences & Healthcare group, specialising in legal regulatory issues affecting life sciences companies operating in the UK and in the EU.

Amelie.Chollet@cms-cmno.com

AI

EC consults on high-risk AI systems in life sciences and healthcare

July 2, 2025

Many life sciences and healthcare companies develop or deploy AI-based medical devices and digital health solutions that may fall within the high-risk category.

Amélie Chollet | CMS, Dr. Roland Wiring3 min read

Topics

Latest News

NYDFS fines dental plan firm $2m in phishing breach

HHS secures $175,000 HIPAA settlement over phishing ransomware breach

DOJ FCPA declination points to continuation of policies and importance of robust compliance

Topics

Latest News

BaFin publishes DORA document requirements cheat sheet

ACER's Q2 2025 REMIT Quarterly: Key takeaways for compliance professionals

FCA strengthens safeguarding regime for payments and e-money firms

Topics

Latest News

Bitcoin lending facility agreements: The HODLER’s path to fiat liquidity

Understanding the UAE's AI strategy: Ambition, investment and regulation

Crypto wrap: American Bitcoin in Asia, new record prices, Do Kwon plea

Topics

Latest News

GRIP Extra: Appeals court clears CFPB takedown, CFTC reviews internal time and attendance compliance

Podcast: Faegre Drinker's Gwen Williamson on AI, digital assets, and SEC priorities

GRIP Extra: SEC launches AI taskforce, Google confirms Salesforce breach

EC consults on high-risk AI systems in life sciences and healthcare